Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
- A study published in Animals: an open access journal from MDPI in 2025 evaluated neutrophil-to-Lymphocyte Ratio as a Promising Non-Invasive Biomarker for Diagnosis of Feline Idiopathic Cystitis in Cats..
Key Findings
Feline idiopathic cystitis (FIC) is a common chronic cystitis disease in cats, accounting for 55-65% of feline lower urinary tract disease (FLUTD). The common clinical symptoms of FIC include pollakiuria, periuria, hematuria, and dysuria. At present, the disease is mainly excluded by evaluating the results of blood, urine, and imaging examinations of diseased animals. There is still a lack of clear and objective indicators for the diagnosis of FIC in clinical practice. Neutrophil-to-lymphocyte ratio (NLR) can be used as an indicator to measure immune inflammatory response and neuroendocrine pressure. It is an economical, efficient, and...
Why It Matters for Veterinary Professionals
For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.
Practical Interpretation
The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.
Clinical Takeaway
Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.
- Read the full article here: https://pubmed.ncbi.nlm.nih.gov/41302015/
Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.